Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.

@article{Rothenbacher2002HomocysteineAM,
  title={Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters.},
  author={Dietrich Rothenbacher and Henry G. Fischer and Albrecht Hoffmeister and Michael M. Hoffmann and Winfried Maerz and Guenter Bode and Jt Rosenthal and Wolfgang K{\"o}nig and Hermann Brenner},
  journal={Atherosclerosis},
  year={2002},
  volume={162 1},
  pages={
          193-200
        }
}
AIM It has been suggested that homocysteine (tHcy) levels and methylenetetrahydrofolate reductase (MTHFR) genotype are primary risk factors for coronary heart disease (CHD). We performed a case-control study to investigate whether tHcy levels and MTHFR genotype (677 C-->T mutation and 1298 A-->C mutation) are associated with CHD under special consideration of the possibility for confounding. METHODS German speaking patients aged 40-68 years who underwent coronary angiography at the University… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: a combined analysis of independent samples.

  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2011
VIEW 2 EXCERPTS
CITES BACKGROUND & RESULTS

Similar Papers

Loading similar papers…